Europe Finance Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Europe Finance Weekly.

Press releases published on April 3, 2026

Muzit’s TRACE Platform Steps Into the Spotlight as Supreme Court Ends ISP Based Piracy Enforcement
Circular Economy Trade Finance Market Size, Share, Competitive Landscape and Trend Analysis Report
Crypto-Powered Remittances Market 2026-2030: Unveiling Growth Developments with the Latest Updates
BFSI Business Intelligence Industry Analysis Report 2026: Key Trends, Drivers, and Forecast Insights
Carbon-Smart Investment Portfolio Market Size Worth $61 Bn by 2030 - Exclusive Report by The Business Research Company
Concierge Auctions: Bidding Open at $3.5M for Rare Boutique Tribeca Penthouse in New York City
Embedded Banking Services Market CAGR to be at 17.8% from 2026 to 2030 | $79 Billion Industry Revenue by 2030
Digital Wallet Market Set to Reach $144.54 Billion by 2030
Edenex Launches DFTP Platform to Digitize Export Financing and Open RWA Investment Access
Halborn Audit Validates QRL's Post-Quantum Cryptography Library
Revised Product Liability Directive risks undermining Single Market coherence, business leaders warn
Empowering Asset Management: Chengdu MIND as a China Leading UHF RFID Tag Solutions Supplier
Green Home Retrofit Loan Platform Market: Future Demand and Top Key Players Analysis | 2030
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
Jena Acquisition Corporation II Announces Non-Compliance with Section 802.01B of the NYSE Listed Company Manual which Requires the Company to Maintain a Minimum of 300 Public Stockholders
Midland States Bancorp, Inc. To Announce First Quarter 2026 Financial Results On Thursday, April 23
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
AIOS Tech Inc. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Share this page:

Sign up for:

Europe Finance Weekly

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.